List of articles used in VitiVar

  1. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population
    2013
    M. Dwivedi, N.C. Laddha, M.S. Mansuri, Y.S. Marfatia and R. Begum
  2. Stress-induced RNASET2 overexpression mediates melanocyte apoptosis via the TRAF2 pathway in vitro
    2014
    Q Wang, M Jiang, J Wu, Y Ma1, T Li, Q Chen, X Zhang and L Xiang
  3. A single-nucleotide polymorphism of miR-196a-2 and vitiligo: an association study and functional analysis in a Han Chinese population
    2013
    Ye Huang, Xiuli Yi, Zhe Jian, Chao Wei, Shuli Li, Chuan Cai, Ping Zhang, Kai Li, Sen Guo, Ling Liu, Qiong Shi, Tianwen Gao and Chunying Li
  4. Transcriptome Analysis Reveals Markers of Aberrantly Activated Innate Immunity in Vitiligo Lesional and Non- Lesional Skin
    2012
    Richard Yu, Raewyn Broady, Yuanshen Huang, Yang Wang, Jie Yu, Min Gao, Megan Levings, Shencai Wei, Shengquan Zhang, Aie Xu, Mingwan Su, Jan Dutz, Xuejun Zhang, Youwen Zhou
  5. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo
    2012
    M. Imran, N.C. Laddha, M. Dwivedi, M.S. Mansuri, J. Singh, R. Rani, R.S. Gokhale, V.K. Sharma, Y.S. Marfatia and R. Begum
  6. Expression of IL-17 and COX2 Gene in Peripheral Blood Leukocytes of Vitiligo Patients
    2011
    Esmaeili, Behnaz; Rezaee, Seyed Abdol Rahim; Layegh, Pouran; Tavakkol Afshari, Jalil; Dye, Phil; Ghayoor Karimiani, Ehsan; Kalalinia, Fatemeh; Rafatpanah, Houshang
  7. Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera
    2008
    Rätsep, R; Kingo, K; Karelson, M; Reimann, E; Raud, K; Silm, H; Vasar, E; Kõks, S
  8. Gene expression analysis of melanocortin system in vitiligo
    2007
    Kingo, Külli; Aunin, Eerik; Karelson, Maire; Philips, Mari-Anne; Rätsep, Ranno; Silm, Helgi; Vasar, Eero; Soomets, Ursel; Kõks, Sulev
  9. Molecular analysis of vitiligo lesions reveals sporadic melanocyte survival
    2007
    G. M. Gottschalk, MBChB, HDip Int Med(SA), FC Derm(SA), and S. H. Kidson,PhD
  10. MYG1, novel melanocyte related gene, has elevated expression in vitiligo.
    2006
    Kingo, Külli; Philips, Mari-Anne; Aunin, Eerik; Luuk, Hendrik; Karelson, Maire; Rätsep, Ranno; Silm, Helgi; Vasar, Eero; Kõks, Sulev
  11. VIT1', a novel gene associated with vitiligo.
    2001
    Le Poole, I C; Sarangarajan, R; Zhao, Y; Stennett, L S; Brown, T L; Sheth, P; Miki, T; Boissy, R E
  12. Increased Tumor Necrosis Factor (TNF)-a and Its Promoter Polymorphisms Correlate with Disease Progression and Higher Susceptibility towards Vitiligo
    2012
    Laddha, Naresh C; Dwivedi, Mitesh; Begum, Rasheedunnisa
  13. Decreased methionine sulphoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo
    2009
    Zhou, Z; Li, C Y; Li, K; Wang, T; Zhang, B; Gao, T W
  14. The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells.
    2012
    Reimann, Ene; Kingo, Külli; Karelson, Maire; Reemann, Paula; Loite, Ulvi; Sulakatko, Helen; Keermann, Maris; Raud, Kristi; Abram, Kristi; Vasar, Eero; Silm, Helgi; Kõks, Sulev
  15. Analysis of the expression profile of CRH-POMC system genes in vitiligo skin biopsies.
    2010
    Reimann, E; Kingo, K; Karelson, M; Salum, T; Aunin, E; Reemann, P; Abram, K; Vasar, E; Silm, H; Kõks, S
  16. Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients.
    2013
    Dwivedi, Mitesh; Laddha, Naresh C; Begum, Rasheedunnisa
  17. Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets.
    2013
    Seif El Nasr, H; Shaker, O G; Fawzi, M M T; El-Hanafi, G
  18. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
    2012
    Kotobuki, Yorihisa; Tanemura, Atsushi; Yang, Lingli; Itoi, Saori; Wataya-Kaneda, Mari; Murota, Hiroyuki; Fujimoto, Minoru; Serada, Satoshi; Naka, Tetsuji; Katayama, Ichiro
  19. Transcriptional upregulation of Nrf2-dependent phase II detoxification genes in the involved epidermis of vitiligo vulgaris.
    2010
    Natarajan, Vivek T; Singh, Archana; Kumar, Avinash A; Sharma, Pankaj; Kar, Hemanta K; Marrot, Laurent; Meunier, Jean-Roch; Natarajan, Krishnamurthy; Rani, Rajni; Gokhale, Rajesh S
  20. Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes.
    2013
    Zhang Y, Liu L, Jin L, Yi X, Dang E, Yang Y, Li C, Gao T.
  21. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients.
    2013
    Ozel Turkcu U, Solak Tekin N, Gokdogan Edgunlu T, Karakas Celik S, Oner S.
  22. Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo.
    2013
    Laddha NC, Dwivedi M, Gani AR, Shajil EM, Begum R.
  23. Altered levels of LXR-α: crucial implications in the pathogenesis of vitiligo.
    2012
    Kumar R, Parsad D, Kanwar AJ, Kaul D.
  24. Serum homocysteine, vitamin B12, folic acid levels and methylenetetrahydrofolate reductase (MTHFR) gene polymorphism in vitiligo.
    2012
    Yasar A, Gunduz K, Onur E, Calkan M.
  25. The association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with generalized vitiligo.
    2012
    Li K(1), Shi Q, Yang L, Li X, Liu L, Wang L, Li Q, Wang G, Li CY, Gao TW.
  26. Expression profile of genes associated with the dopamine pathway in vitiligo skin biopsies and blood sera
    2012
    Reimann E(1), Kingo K, Karelson M, Reemann P, Loite U, Keermann M, Abram K, Vasar E, Silm H, Kõks S.
  27. Expression of InnVit/FBXO11 in vitiligo and its role in tyrosinase export from endoplasmic reticulum
    2010
    Guan CP(1), Lin FQ, Hong WS, Fu LF, Zhou MN, Xu W, Xu AE
  28. Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.
    2010
    Philips MA(1), Kingo K, Karelson M, Rätsep R, Aunin E, Reimann E, Reemann P, Porosaar O, Vikeså J, Nielsen FC, Vasar E, Silm H, Kõks S.
  29. Dysfunction of glutathione S-transferase leads to excess 4-hydroxy-2-nonenal and H(2)O(2) and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients.
    2010
    Kostyuk VA(1), Potapovich AI, Cesareo E, Brescia S, Guerra L, Valacchi G, Pecorelli A, Deeva IB, Raskovic D, De Luca C, Pastore S, Korkina LG.
  30. Protease-activated receptor-2 downregulation is associated to vitiligo lesions.
    2009
    Moretti S, Nassini R, Prignano F, Pacini A, Materazzi S, Naldini A, Simoni A, Baroni G, Pellerito S, Filippi I, Lotti T, Geppetti P, Massi D.
  31. Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo.
    2008
    Kingo K(1), Aunin E, Karelson M, Rätsep R, Silm H, Vasar E, Kõks S.
  32. Transcriptional profiling of melanocytes from patients with vitiligo vulgaris.
    2008
    Strömberg S(1), Björklund MG, Asplund A, Rimini R, Lundeberg J, Nilsson P, Pontén F, Olsson MJ
  33. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
    2004
    Kitamura R1, Tsukamoto K, Harada K, Shimizu A, Shimada S, Kobayashi T, Imokawa G.
  34. Butyrylcholinesterase is present in the human epidermis and is regulated by H2O2: more evidence for oxidative stress in vitiligo.
    2006
    Schallreuter KU1, Gibbons NC, Zothner C, Elwary SM, Rokos H, Wood JM.
  35. The role of heat shock proteins (HSPs) in vitiligo: deviation of cytotoxic response?
    2005
    Ippoliti F, Frediani T, Santis WD, Lucarelli S, Canitano N, Frediani S, Frati C.
  36. DKK1 is highly expressed in the dermis of vitiligo lesion: is there association between DKK1 and vitiligo?
    2012
    Oh SH, Kim JY, Kim MR, Do JE, Shin JY, Hann SK.
  37. Reduced Aquaporin3 Expression and Survival of Keratinocytes in the Depigmented Epidermis of Vitiligo
    2010
    Nan-Hyung Kim1 and Ai-Young Lee1
  38. The Ca2+-binding capacity of epidermal furin is disrupted by H2O2-mediated oxidation in vitiligo.
    2008
    Spencer JD1, Gibbons NC, Böhm M, Schallreuter KU.
  39. Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo.
    2013
    Dwivedi M, Laddha NC, Shah K, Shah BJ, Begum R.
  40. Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo.
    2003
    Casp CB1, She JX, McCormack WT.
  41. Platelet-derived growth factor receptor alpha gene mutations in vitiligo vulgaris.
    2010
    Xu S(1), Zhou Y, Yang S, Ren Y, Zhang C, Quan C, Gao M, He C, Chen H, Hhan J, Chen J, Liang Y, Yang J, Sun L, Yin X, Liu J, Zhang X.
  42. Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility.
    2013
    Laddha NC1, Dwivedi M, Gani AR, Mansuri MS, Begum R.
  43. Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.
    2016
    Dey-Rao R, Sinha AA
  44. Differential expression of mRNA for T-bet and GATA-3 transcription factors in peripheral blood mononuclear cells of patients with vitiligo.
    2015
    Nouri-Koupaee A, Mansouri P, Jahanbini H, Sanati MH, Jadali Z
  45. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo.
    2016
    Elgarhy LH, Abdullatif A, Abdelazim R, El-Desouky KI
  46. Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin.
    2012
    Ricard AS1, Pain C, Daubos A, Ezzedine K, Lamrissi-Garcia I, Bibeyran A, Guyonnet-Dupérat V, Taieb A, Cario-André M.
  47. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin
    2009
    P. V. Sravani, N. Kishore Babu1, K. V. T. Gopal, G. Raghu Rama Rao, Athota Rama Rao1, Bhagavatula Moorthy 2, T. Raghava Rao1
  48. Liver X receptor expression in human melanocytes, does it have a role in the pathogenesis of vitiligo?
    2009
    Kumar R, Parsad D, Kaul D, Kanwar AJ.
  49. Immunohistochemical expression of heat shock protein 70 in vitiligo.
    2013
    Abdou AG1, Maraee AH, Reyad W.
  50. Reduced immunohistochemical expression of Discoidin Domain Receptor 1 (DDR1) in vitiligo skin.
    2013
    Reichert-Faria A, Jung JE, Moreschi Neto V, de Castro CC, Mira MT, Noronha L.
  51. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo.
    2011
    Kumar R1, Parsad D, Kanwar AJ, Kaul D.
  52. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
    2002
    van den Wijngaard RM1, Asghar SS, Pijnenborg AC, Tigges AJ, Westerhof W, Das PK.
  53. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: An implication for pathogenesis
    2014
    Seleit I1, Bakry OA2, Abdou AG3, Dawoud NM1.
  54. Oxidative stress level and tyrosinase activity in vitiligo patients.
    2010
    Eskandani M1, Golchai J, Pirooznia N, Hasannia S.
  55. Genetic variations in nalp1 mRNA expressions in human vitiligo.
    2011
    Deo SS1, Bhagat AR, Shah RN.
  56. Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in patients with vitiligo.
    2012
    Karadag AS1, Tutal E, Ertugrul DT, Akin KO, Bilgili SG.
  57. Interleukin-33 affects cytokine production by keratinocytes in vitiligo.
    2014
    Li P1, Ma H, Han D, Mou K.
  58. Immunohistochemical detection of P53 and Mdm2 in vitiligo.
    2012
    Bakry OA1, Hammam MA, Wahed MM.
  59. Impact of HLA-G in the outcome of vitiligo in Tunisian patients.
    2010
    Jalel A1, Ridha A, Laurent D, Philippe M, Hamdaoui MH.
  60. Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo.
    2006
    Birol A, Kisa U, Kurtipek GS, Kara F, Kocak M, Erkek E, Caglayan O.
  61. Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.
    2017
    Dey-Rao R, Sinha AA.
  62. Immunohistochemical Analysis of GDNF and Its Cognate Receptor GFRα-1 Protein Expression in Vitiliginous Skin Lesions.
    2016
    Adly MA, Assaf HA, Abdel-Rady SF, Ahmed NS, Hussein MR
  63. Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients.
    2015
    Regazzetti C, Joly F, Marty C, Rivier M, Mehul B, Reiniche P, Mounier C, Rival Y, Piwnica D, Cavalié M, Chignon-Sicard B, Ballotti R, Voegel J, Passeron T
  64. Assessment of gene expression levels of proopiomelanocortin (POMC) and melanocortin-1 receptor (MC1R) in vitiligo
    2017
    Nagui NA, Mahmoud SB, Abdel Hay RM, Hassieb MM, Rashed LA
  65. Vitamin D Receptor Expression in Vitiligo.
    2015
    Doss RW, El-Rifaie AA, Gohary YM, Rashed LA.
  66. Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients.
    2014
    Reimann E, Kingo K, Karelson M, Reemann P, Vasar E, Silm H, Kõks S
  67. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo.
    2016
    Vaccaro M, Cicero F, Mannucci C, Calapai G, Spatari G, Barbuzza O, Cannavò SP, Gangemi S
  68. The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual.
    2016
    Wang P, Li Y, Nie H, Zhang X, Shao Q, Hou X, Xu W, Hong W, Xu A
  69. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo
    2016
    Wang XX, Wang QQ, Wu JQ, Jiang M, Chen L, Zhang CF, Xiang LH
  70. Immunohistochemical expression of Aquaporin-3 protein in vitiligo; a new potential guide for disease activity.
    2016
    Hodeib A, Hegab D, Rizk O, Mohammed S.
  71. Heat Shock Protein-70 Expression in Vitiligo and its Relation to the Disease Activity.
    2016
    Doss RW, El-Rifaie AA, Abdel-Wahab AM, Gohary YM, Rashed LA
  72. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo
    2016
    Zhen Y, Yao L, Zhong S, Song Y, Cui Y, Li S
  73. Differential expression of CXCL9, CXCL10, and IFN-γ in vitiligo and alopecia areata patients.
    2017
    Maouia A, Sormani L, Youssef M, Helal AN, Kassab A, Passeron T
  74. Increased systemic and epidermal levels of IL-17A and IL-1β promotes progression of non-segmental vitiligo.
    2017
    Bhardwaj S, Rani S, Srivastava N, Kumar R, Parsad D.
  75. Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin.
    2016
    Bakry OA, Hagag MM, Kandil MA, Shehata WA
  76. Regulatory T-cell cytokines in patients with nonsegmental vitiligo.
    2017
    Kidir M, Karabulut AA, Ercin ME, Atasoy P
  77. The expression of alpha-MSH by melanocytes is reduced in vitiligo.
    1999
    Graham A1, Westerhof W, Thody AJ.